Rate My Professor Daniel Malone

Daniel Malone is an Associate Professor in Pharmacy and Pharmaceutical Sciences Education at Monash University, Faculty of Pharmacy and Pharmaceutical Sciences, where he serves as Course Director of the Undergraduate Pharmacy Degree. He holds a BPharm (Hons) and a PhD in Pharmacology from Monash University (1996-2000). His career includes progression from Lecturer and Senior Lecturer to Associate Professor, with roles as academic lead for the integrated Master of Pharmacy, third-year level coordinator for the Bachelor of Pharmacy, and Director of Pharmacy Education. Malone lectures in physiology, pharmacology, biochemistry, and clinical pharmacy, specializing in neurophysiology, pharmacology of central nervous system disorder treatments, and over-the-counter medicines for community pharmacy practice. He also maintains clinical practice as Pharmacist in Charge at Newton's Pharmacy since 2017.

Malone's research focuses on pharmacy education, assessment, and case-based learning, with contributions to UN Sustainable Development Goals in good health and quality education. Key publications include 'Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models' (2010), 'Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice' (2006), 'Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor' (2015), 'How do interruptions and distractions affect pharmacy practice? A scoping review' (2025), and 'Substitution of a Traditional Face-to-Face Workshop with Virtual Escape Room in Higher Education' (2025). He has received the American Associated Colleges of Pharmacy Innovation in Teaching Award (2022), Monash Education Excellence: Teaching Excellence (2022), Excellence in Teaching: Programs that Enhance Student Learning (2015), Office of Learning & Teaching Citation for Outstanding Contributions to Student Learning (2012), and a 2024 program award recognition. Malone serves on the Examinations Committee (since 2019) and Accreditation Assessment Team (since 2023) of the Australian Pharmacy Council, and contributes media commentary on health topics.